Akero Therapeutics Inc Long-term Investment Intensity
Akero Therapeutics Inc long-term investment intensity. Akero Therapeutics Inc (AKRO) has a Long-term Investment Intensity of 24.9% as of September 2025. Long-term investments of $250.49 Million represent 24.9% of total assets of $1.01 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See working capital to net assets of Akero Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Akero Therapeutics Inc (2023–2024)
Long-term investment intensity of Akero Therapeutics Inc from 2023 to 2024. This chart shows how Akero Therapeutics Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2023 to 2024. As of September 2025, the intensity stands at 24.9%, reflecting long-term investments of $250.49 Million against total assets of $1.01 Billion USD. See AKRO cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Akero Therapeutics Inc Long-term Investment Intensity by Year (2023–2024)
Akero Therapeutics Inc long-term investment intensity by year from 2023 to 2024. The table below presents the year-by-year Long-term Investment Intensity for Akero Therapeutics Inc from 2023 to 2024, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see AKRO total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 6.6% | $54.75 Million | $825.89 Million | ▲ +3.3 pp |
| 2023 | 3.3% | $19.28 Million | $580.27 Million | — |